神经损伤的体重不足危重患者静脉血栓栓塞预防实践模式
本研究为6年回顾性研究,纳入神经内科/神经外科ICU收治的成人神经损伤患者,要求住院≥72小时、有VTE预防医嘱且BMI<30 kg/m2,按体重不足(BMI≤18.5 kg/m2或体重≤50.0 kg)与非肥胖(BMI 18.6-29.9 kg/m2)2:1匹配(匹配因素为年龄、诊断和疾病严重程度)。体重不足组(n=107)与非肥胖组(n=214)最常用方案均为普通肝素5000单位皮下注射每12小时一次(69.1% vs 83.6%;p=0.003),仅体重不足组接受普通肝素2500单位皮下注射每12小时一次(17.8% vs 0.0%;p<0.0001)。接受VTE预防期间总体出血和血栓事件比例无显著差异,但体重不足患者接受预防期间颅内血肿扩大比例显著高于非肥胖患者(45.5% vs 8.3%;p=0.017);接受>150 units/kg/day普通肝素者出血风险有增加趋势(9.7% vs 4.2%;p=0.064)。作者认为,当前实践未对神经损伤体重不足患者进行剂量调整,使用增加剂量普通肝素和/或可能暴露于>150 units/kg/day普通肝素时应谨慎。
要点
- 神经损伤体重不足患者接受VTE预防时颅内血肿扩大比例显著高于非肥胖患者(45.5% vs 8.3%;p=0.017)。
- 体重不足组与非肥胖组最常用方案均为普通肝素5000单位皮下注射每12小时一次(69.1% vs 83.6%;p=0.003)。
- 仅体重不足组接受普通肝素2500单位皮下注射每12小时一次(17.8% vs 0.0%;p<0.0001)。
- 接受>150 units/kg/day普通肝素者出血风险有增加趋势(9.7% vs 4.2%;p=0.064)。
- 作者认为,当前实践未对神经损伤体重不足患者进行剂量调整,使用增加剂量普通肝素和/或可能暴露于>150 units/kg/day普通肝素时应谨慎。
适用人群与场景
- 成人神经损伤患者,收治于神经内科/神经外科ICU,住院≥72小时且有VTE预防医嘱,BMI<30 kg/m2。
- 体重不足组:BMI≤18.5 kg/m2或体重≤50.0 kg;非肥胖组:BMI 18.6-29.9 kg/m2。
处置流程与药物剂量
- 体重不足组最常用方案为普通肝素5000单位皮下注射每12小时一次(69.1%)。
- 非肥胖组最常用方案为普通肝素5000单位皮下注射每12小时一次(83.6%)。
- 仅体重不足组接受普通肝素2500单位皮下注射每12小时一次(17.8%)。
研究设计与关键结果
- 回顾性研究,纳入6年间神经内科/神经外科ICU的成人神经损伤患者,体重不足组n=107,非肥胖组n=214,按年龄、诊断和疾病严重程度2:1匹配。
- 体重不足组vs非肥胖组最常用普通肝素5000单位皮下注射每12小时一次的比例为69.1% vs 83.6%(p=0.003)。
- 仅体重不足组接受普通肝素2500单位皮下注射每12小时一次(17.8% vs 0.0%;p<0.0001)。
- 接受VTE预防期间总体出血和血栓事件比例无显著差异。
- 体重不足患者接受预防期间颅内血肿扩大比例显著高于非肥胖患者(45.5% vs 8.3%;p=0.017)。
- 接受>150 units/kg/day普通肝素者出血风险有增加趋势(9.7% vs 4.2%;p=0.064)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,当前实践未对神经损伤体重不足患者进行剂量调整。
- 作者认为,使用增加剂量普通肝素和/或可能暴露于>150 units/kg/day普通肝素时,在神经损伤体重不足患者中应谨慎。
- 作者认为,需要继续评估VTE预防以确认这些发现。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Venous thromboembolism (VTE) prophylaxis in underweight patients with neurologic injury remains unaddressed by guidelines and primary literature. This study aimed to describe VTE prophylaxis strategies employed in this population and compare the impact of underweight and non-obese patients on thrombotic and bleeding events.
METHODS: A retrospective review of adults admitted with a diagnosis of neurologic injury to a neurology/neurosurgery intensive care unit (ICU) over 6 years. Patients admitted ≥72 h with an order for VTE prophylaxis during admission, and a body mass index (BMI) <30 kg/m2 were included. Patients were stratified to underweight (BMI ≤18.5 kg/m2 or weight ≤50.0 kg) or non-obese (BMI 18.6-29.9 kg/m2) groups and matched, 2:1, on age, diagnosis, and disease severity.
RESULTS: The most common regimen in the underweight (n = 107) and non-obese (n = 214) group was unfractionated heparin (UFH) 5000 units subcutaneously Q12 h (69.1 vs. 83.6%; p = 0.003). Only underweight patients received UFH 2500 units subcutaneously Q12 h (17.8 vs. 0.0%; p < 0.0001). The proportion of overall bleeding and thrombotic events while receiving VTE prophylaxis was not significantly different. The proportion of underweight patients developing intracranial hematoma expansion while receiving prophylaxis versus non-obese patients (45.5 vs. 8.3%; p = 0.017) was significant. Patients receiving >150 units/kg/day of UFH displayed a trend toward increased risk of bleeding (9.7 vs. 4.2%; p = 0.064).
CONCLUSIONS: Current practice does not reflect dose reductions for neurologically injured, underweight patients. Caution should be considered when using increased doses of UFH in neurologically injured patients that are underweight and/or may be exposed to >150 units/kg/day of UFH. Continued assessment of VTE prophylaxis is needed to confirm these findings.
参考来源
- Betthauser K, Pope H, Gowan M, et al. Practice Patterns of Venous Thromboembolism Prophylaxis in Underweight, Critically Ill Patients with Neurologic Injury. Neurocrit Care. 2017. PMID: 28097621. doi:10.1007/s12028-016-0373-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。